Estradiol with levonorgestrel
Brand names: FemSeven Conti, FemSeven Sequi
A combined hormone replacement therapy of estradiol with the progestogen levonorgestrel, used to treat menopausal symptoms in women with a uterus, often as a continuous combined preparation.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Estradiol relieves oestrogen-deficiency symptoms while levonorgestrel opposes endometrial proliferation, allowing a bleed-free regimen in suitably postmenopausal women.
Prescribing in practice
- Levonorgestrel is present to protect the endometrium against unopposed oestrogen, so it is essential for women who retain a uterus and the product should not be substituted with oestrogen alone.
- Continuous combined regimens suit women who are clearly postmenopausal; breakthrough bleeding in the early months is common but persistent bleeding needs investigation.
- Weigh thrombotic, stroke and breast cancer risk and avoid in active thromboembolic disease or oestrogen-dependent malignancy.
Monitoring
Monitor symptom response, blood pressure and bleeding pattern, and investigate bleeding that persists or starts after an initial settled phase.
Counselling the patient
- Some irregular bleeding or spotting is common in the first few months but report bleeding that persists or recurs.
- Seek urgent advice for breast changes or symptoms of a clot.
- Attend routine breast and cervical screening.
Evidence & guidelines
NICE menopause guidance underpins the use of combined continuous oestrogen-progestogen hormone replacement therapy in postmenopausal women.
Reference: NICE NG23; British Menopause Society; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21